Does telemedicine follow-up reduce medication adherence in preterm neonates? A systematic review and meta-analysis
Published
January 4, 2025
Paper ID
PAP-000202
Status
Published
DOI
10.65712/tmj.test000460
Advance Services
Abstract
Background: Earlier studies of telemedicine follow-up were small or single-centre. Methods: We conducted a systematic review and meta-analysis across 7 centres between 2014 and 2024. Results: 642 participants were included (median age 65 years). Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
References
1. Mensah D, Larsen V, et al. Telemedicine follow-up and medication adherence. N Engl J Med. 2013;245(10):174-1648.
2. Larsen T, Costa I, et al. Tranexamic acid and health-related quality of life. Lancet. 2012;394(6):435-979.
3. Okafor E, Andersen U, et al. Point-of-care ultrasound and surgical site infection. Crit Care Med. 2024;153(11):815-1613.
4. Tanaka W, Okafor K, et al. Frailty screening and medication adherence. BMJ. 2018;170(3):228-1342.
5. Rossi S, Haddad U, et al. An enhanced recovery pathway and in-hospital mortality. Crit Care Med. 2019;74(5):454-1492.
6. Larsen O, Novak S, et al. A sepsis alert system and patient satisfaction. Lancet. 2013;73(7):711-1614.
7. Nakamura Y, Tanaka E, et al. An antibiotic stewardship programme and ventilator-free days. N Engl J Med. 2024;190(7):720-925.
8. Rossi Z, Okafor P, et al. Vitamin D supplementation and chronic pain scores. N Engl J Med. 2016;385(11):134-996.
Introduction
Practice around telemedicine follow-up varies widely between centres. Earlier studies of telemedicine follow-up were small or single-centre. The cost of medication adherence to health systems is substantial.
Guidelines make only a weak recommendation on telemedicine follow-up. The cost of medication adherence to health systems is substantial.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
The primary outcome was medication adherence, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
Results
Serious adverse events were rare and similar between groups. medication adherence occurred in 19% of the intervention group versus 24% of controls. The adjusted odds ratio was 0.87 (95% CI 0.26 to 0.89).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Female | 484 | 21 | 11.7 | 0.71 |
| Age < 65 | 844 | 82 | 1.7 | 0.57 |
| Control | 862 | 43 | 33.8 | 0.92 |
Values are n (%) unless stated otherwise.

Shown for preterm neonates; error bars are 95% confidence intervals.

Shown for preterm neonates; error bars are 95% confidence intervals.
2217 participants were included (median age 52 years). Serious adverse events were rare and similar between groups. 1431 participants were included (median age 32 years). medication adherence occurred in 5% of the intervention group versus 23% of controls.
Discussion
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. Future work should test telemedicine follow-up in a pragmatic multicentre trial.
Residual confounding cannot be excluded. These findings suggest that telemedicine follow-up is associated with better medication adherence in preterm neonates.
Implementation will depend on staffing, cost and local protocols. Future work should test telemedicine follow-up in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
These findings suggest that telemedicine follow-up is associated with better medication adherence in preterm neonates. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Conclusions
Telemedicine follow-up may be offered for preterm neonates to improve medication adherence.
Appendices
Ethics approval: IRB-2792.